Healthcare provider profile · identity verified

Grantley Joseph, M.D.

Internal Medicine · DECATUR, GA · NPI 1861506016

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1158	365
Amlodipine Besylate	Amlodipine Besylate	1092	328
Metformin Hcl	Metformin Hcl	466	143
Lisinopril	Lisinopril	323	97
Metoprolol Succinate	Metoprolol Succinate	297	93
Rosuvastatin Calcium	Rosuvastatin Calcium	289	100
Losartan Potassium	Losartan Potassium	279	90
Hydrochlorothiazide	Hydrochlorothiazide	270	87
Omeprazole	Omeprazole	234	69
Tamsulosin Hcl	Tamsulosin Hcl	202	63
Potassium Chloride	Potassium Chloride	192	55
Pravastatin Sodium	Pravastatin Sodium	189	50
Nifedipine Er	Nifedipine	179	55
Zolpidem Tartrate	Zolpidem Tartrate	178	31
Pioglitazone Hcl	Pioglitazone Hcl	167	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	164	48
Meloxicam	Meloxicam	160	49
Jardiance	Empagliflozin	159	44
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	158	47
Gabapentin	Gabapentin	157	57
Glimepiride	Glimepiride	153	43
Levothyroxine Sodium	Levothyroxine Sodium	152	44
Januvia	Sitagliptin Phosphate	145	37
Fluticasone Propionate	Fluticasone Propionate	142	52
Allopurinol	Allopurinol	140	41
Albuterol Sulfate Hfa	Albuterol Sulfate	137	53
Simvastatin	Simvastatin	134	39
Alendronate Sodium	Alendronate Sodium	125	36
Ibandronate Sodium	Ibandronate Sodium	116	41
Eliquis	Apixaban	112	32
Furosemide	Furosemide	110	34
Pantoprazole Sodium	Pantoprazole Sodium	110	44
Trulicity	Dulaglutide	105	22
Hydralazine Hcl	Hydralazine Hcl	103	33
Glipizide Er	Glipizide	99	28
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	98	29
Chlorthalidone	Chlorthalidone	93	33
Ezetimibe	Ezetimibe	93	28
Spironolactone	Spironolactone	93	30
Carvedilol	Carvedilol	88	34
Ozempic	Semaglutide	88	23
Glipizide	Glipizide	85	24
Metformin Hcl Er	Metformin Hcl	83	24
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	79	21
Atenolol	Atenolol	77	23
Mirtazapine	Mirtazapine	75	31
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	73	19
Candesartan Cilexetil	Candesartan Cilexetil	72	21
Tradjenta	Linagliptin	70	17
Farxiga	Dapagliflozin Propanediol	67	19
Triamcinolone Acetonide	Triamcinolone Acetonide	67	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	27
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	61	17
Metoprolol Tartrate	Metoprolol Tartrate	59	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	58	52
Escitalopram Oxalate	Escitalopram Oxalate	57	22
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	56	16
Sertraline Hcl	Sertraline Hcl	53	15
Ibuprofen	Ibuprofen	52	31
Labetalol Hcl	Labetalol Hcl	51	15
Tramadol Hcl	Tramadol Hcl	51	19
Valacyclovir	Valacyclovir Hcl	50	18
Meclizine Hcl	Meclizine Hcl	49	20
Famotidine	Famotidine	48	18
Diclofenac Sodium	Diclofenac Sodium	45	13
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	44	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	44	14
Olmesartan Medoxomil	Olmesartan Medoxomil	44	13
Oxybutynin Chloride Er	Oxybutynin Chloride	43	11
Benazepril Hcl	Benazepril Hcl	42	15
Clopidogrel	Clopidogrel Bisulfate	42	18
Montelukast Sodium	Montelukast Sodium	42	17
Mounjaro	Tirzepatide	42	suppressed
Valsartan	Valsartan	40	14
Naproxen	Naproxen	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	12
Trazodone Hcl	Trazodone Hcl	37	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	12
Myrbetriq	Mirabegron	36	suppressed
Clonidine Hcl	Clonidine Hcl	34	11
Methylprednisolone	Methylprednisolone	33	32
Terazosin Hcl	Terazosin Hcl	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	32	13
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	31	suppressed
Nebivolol Hcl	Nebivolol Hcl	28	suppressed
Azithromycin	Azithromycin	27	25
Novolog Flexpen	Insulin Aspart	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	13
Finasteride	Finasteride	25	suppressed
Sildenafil Citrate	Sildenafil Citrate	25	suppressed
Colchicine	Colchicine	24	11
Ketoconazole	Ketoconazole	24	19
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	21
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	22	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Linzess	Linaclotide	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Ibu	Ibuprofen	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Victoza 3-Pak	Liraglutide	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Cephalexin	Cephalexin	18	14
Levetiracetam	Levetiracetam	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Ramipril	Ramipril	18	suppressed
Torsemide	Torsemide	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pioglitazone-Metformin	Pioglitazone Hcl/Metformin Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Estradiol	Estradiol	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error